Sean A. McCarthy - Mar 19, 2024 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Stock symbol
CTMX
Transactions as of
Mar 19, 2024
Transactions value $
-$42,175
Form type
4
Date filed
3/21/2024, 04:40 PM
Previous filing
Jan 19, 2024
Next filing
Mar 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale -$42.2K -20.2K -3.71% $2.09 524K Mar 19, 2024 Direct F1, F2
holding CTMX Common Stock 93.2K Mar 19, 2024 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
F2 Includes 197,500 restricted stock units.
F3 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.